For instance, by targeting SOX4, miR‐130a‐5p served as a tumour inhibitor in gastric cancer.3 Interestingly, in vitro studies showed that SOx4 expression was repressed by overexpression of miR‐130a‐5p and enhanced by blocking of miR‐130a‐5p. The gene discussed is SOX4; the disease is neoplasm.